Cargando…
367 Designing an Untargeted Metabolomics Assay to Detect Biomarkers for Inborn Errors of Metabolism in the Clinical Laboratory
OBJECTIVES/GOALS: To develop an untargeted metabolomics assay that can holistically characterize the small molecule signatures of different inborn errors of metabolism (IEM) for biomarker discovery and identification of novel IEMs, with the goal of implementing the assay into the clinical laboratory...
Autores principales: | Wurth, Rachel, Turgeon, Coleman, ZinandréStander, Gavrilov, Dimitar, Hall, Patricia, Matern, Dietrich, Schultz, Matthew, Tortorelli, Silvia, Oglesbee, Devin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129500/ http://dx.doi.org/10.1017/cts.2023.405 |
Ejemplares similares
-
The Combined Impact of CLIR Post-Analytical Tools and Second Tier Testing on the Performance of Newborn Screening for Disorders of Propionate, Methionine, and Cobalamin Metabolism
por: Gavrilov, Dimitar K., et al.
Publicado: (2020) -
Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics
por: Ismail, Israa T, et al.
Publicado: (2019) -
Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism
por: Miller, Marcus J., et al.
Publicado: (2015) -
Allelic spectrum of formiminotransferase‐cyclodeaminase gene variants in individuals with formiminoglutamic aciduria
por: Majumdar, Ramanath, et al.
Publicado: (2017) -
Using Out-of-Batch Reference Populations to Improve Untargeted Metabolomics for Screening Inborn Errors of Metabolism
por: Bongaerts, Michiel, et al.
Publicado: (2020)